# ID Ventures

> ID Ventures is a VC fund in Seoul backing Software, Health Care and Media and Entertainment. See 25 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Seoul, South Korea
- Total investments: 25
- Last investment: Dec 2025
- Lead investor: 4%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/id-ventures/
- Website: http://www.id-vc.com/

ID Ventures is a VC fund in Seoul focused on Software and Health Care. ID Ventures Co., Ltd. is a venture capital firm that discover, invest in and foster companies with innovation that change lives.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 5 | 20% |
| Health Care | 5 | 20% |
| Media and Entertainment | 3 | 12% |
| SaaS | 2 | 8% |
| Content | 2 | 8% |

53 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 40% |
| Series B | 7 | 28% |
| Seed | 4 | 16% |
| Funding Round | 2 | 8% |
| Venture - Series Unknown | 1 | 4% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| South Korea | 16 | 64% |
| United States | 5 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Meissa | Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling. The company digitalizes sites with spatial data, such as design level comparison, and overlays floor plans collected by drone, as well as does three-dimensional modeling of projects, enabling companies to complete construction smartly. | $6.8M | Venture - Series Unknown | Dec 23, 2025 |  |
| EMX | EMX is a content production company focused on delivering narrative expression through visual art. It utilizes deep learning-based digital twin technology to develop virtual environments for large-scale content creation, providing visual effects (VFX) companies with end-to-end technical support across concept design, key visuals, previsualization,and production. The platform enables users to trade perpetual swaps and futures across crypto, commodities, forex, and equity markets using digital assets as collateral. | $2.7M | Seed | Dec 03, 2025 |  |
| Sirs | Sirs is a men's medical healthcare platform that offers non-face-to-face treatment, drug delivery, and consultation services. |  | Seed | Apr 26, 2022 |  |
| Lion Rocket | LionRocket develops generative AI tools for image, video, and webtoon content production. The company provides AI-based character generation, pose control, voice synthesis, and digital human technologies through platforms used for content creation, visual storytelling, and media production workflows. | $5.5M | Series A | Dec 16, 2021 |  |
| adoc | ADOC develops AI-based medical information and symptom analysis platforms that provide digital healthcare solutions helping users understand health conditions through data-driven insights and structured medical information systems. The company focuses on improving accessibility to healthcare knowledge through technology-driven tools andpersonalized health guidance services. | $5M | Series A | Nov 22, 2021 |  |
| Enfusion | Enfusion is a developer of mobile and PC games |  | Series A | Sep 27, 2021 |  |
| Sevenbroi Beer | Sevenbroi Beer manufactures homemade beers. | $12.3M | Series A | Jul 07, 2021 |  |
| Trost | Trost | $2.7M | Series A | Jun 01, 2021 |  |
| Ripple Science | Ripple Science delivers web-based software and an active registry that facilitates the recruitment and management of research participants for clinical and translational studies. By adapting sales and marketing automation tools to the process of participant recruitment, Ripple empowers its customers to recruit more participants faster.Thecompany's flagship product, Ripple SaaS, is currently being used by research investigators at more than 75 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia, Cognito Therapeutics, and the University of Michigan. | $2.5M |  | Jan 07, 2020 |  |
| Ripple Science | Ripple Science delivers web-based software and an active registry that facilitates the recruitment and management of research participants for clinical and translational studies. By adapting sales and marketing automation tools to the process of participant recruitment, Ripple empowers its customers to recruit more participants faster.Thecompany's flagship product, Ripple SaaS, is currently being used by research investigators at more than 75 academic and research centers around the world, including Johns Hopkins University, Pennsylvania State University, University of California Los Angeles, the Brain Research Foundation Canada, University of East Anglia, Cognito Therapeutics, and the University of Michigan. | $2.5M | Seed | Jan 07, 2020 |  |

10 of 25 investments shown.

## Co-investors
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund, 3 deals together
- [Aju IB Investment](https://shizune.co/investors/profile/aju-ib-investment) — VC Fund, 2 deals together
- [Atinum Partners](https://shizune.co/investors/profile/atinum-investment) — VC Fund, 2 deals together
- [Devsisters Ventures](https://shizune.co/investors/profile/devsisters-ventures) — VC Fund, 2 deals together
- [Dundee Venture Capital](https://shizune.co/investors/profile/dundee-venture-capital) — VC Fund, 2 deals together
- [Industrial Bank of Korea](https://shizune.co/investors/profile/industrial-bank-of-korea) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Strong Ventures](https://shizune.co/investors/profile/strong-ventures) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund
- [Kakao Ventures](https://shizune.co/investors/profile/kakao-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in South Korea](https://shizune.co/investors/health-care-investors-south-korea)
- [Health Care VC Funds in South Korea](https://shizune.co/investors/health-care-vc-funds-south-korea)
- [Biotech Investors in South Korea](https://shizune.co/investors/biotech-investors-south-korea)
- [Biotech VC Funds in South Korea](https://shizune.co/investors/biotech-vc-funds-south-korea)
- [Medical VC Funds in South Korea](https://shizune.co/investors/medical-vc-funds-south-korea)
- [Biotechnology Investors in South Korea](https://shizune.co/investors/biotechnology-investors-south-korea)

## FAQ

### What does ID Ventures invest in?

ID Ventures invests primarily in Software, Health Care and Media and Entertainment startups, most often at Series A and Series B stage. Most of the 25 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ID Ventures last invest?

The most recent investment recorded for ID Ventures closed in Dec 2025. Shizune tracks 25 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co